Laboratory Standardisation Panel. Current status of blood cholesterol measurement in clinical laboratories in the United States: A report from the Laboratory Standardisation Panel of the National Cholesterol Education Program. Clin Chem1988; 34: 193–201.
2.
European Atherosclerosis Society. Prevention of coronary heart disease: Scientific background and new clinical guidelines. Nutr Metab Cardiovasc Dis1992; 2: 113–56.
3.
BetteridgeDJDodsonPMHughesEALakerMFNichollsDPReesJAEDetection and management of hyperlipidaemia. Guidelines of the British Hyperlipidaemia Association. Postgrad Med J1993; 69: 359–69.
4.
FreemantleNLongAMasonJSheldonTSongFWilsonC.Cholesterol: Screening and treatment. Effect Hlth Care1993; 6: 1–8.
5.
SmithGDSongFSheldonTA. Cholesterol lowering and mortality: The importance of considering initial level of risk. BMJ1993; 306: 1367–73.
6.
PackardCJBellMAEatonRHDagenMMCassidyMShepherdJ.A pilot scheme for the standardisation of serum cholesterol measurement in Scotland and Northern Ireland. Ann Clin Biochem1993; 30: 387–93.
7.
RaoDCMortonNEGulbrandsenCLRhoadsGGKaganAYeeS.Cultural and biological determinants of lipoprotein concentrations. Ann Hum Genet1979; 42: 467–77.
8.
RaoDCLaskarzewskiPMMorrisonJAKhouryPKellyKWetteRThe Cincinnati Lipid Research Clinic Family Study: Cultural and biological determinants of lipids and lipoprotein concentrations. Am J Hum Genet1982; 34: 888–903.
9.
FriedlanderYKarkJDSteinY.Biological and environmental sources of variation in plasma lipids and lipoproteins: The Jerusalem lipid research clinic. Hum Hered1986; 36: 143–53.
10.
KafonekSDDerbyCABachorikPS. Biological variability of lipoproteins and apolipoproteins in patients referred to a lipid clinic. Clin Chem1992; 38: 864–7.
11.
BrownSABoerwinkleEKashanianFKSwansonNPatschW.Variation in concentrations of lipids, lipoprotein lipids, and apolipoproteins A-1 and B in plasma from healthy women. Clin Chem1990; 36: 207–10.
12.
CooperGRMyersGLSmithSJSchlantRC. Blood lipid measurements. Variations and practical utility. J Am Med Assoc1992; 267: 1652–60.
13.
DemackerPNMSchadeRWBJansenRTPVan't LaarA.Intra-individual variation of serum cholesterol, triglycerides and high density lipoprotein cholesterol in normal humans. Atherosclerosis1982; 45: 259–66.
14.
WaseniusAStugaardMOtterstadJEFroyshovD.Diurnal and monthly intra-individual variability of the concentration of lipids, lipoproteins and apoproteins. Scand J Clin Lab Invest1990; 50: 635–42.
15.
MiettinenTA. Diurnal variation of cholesterol precursors squalene and methyl sterols in human plasma lipoproteins. J Lipid Res1982; 23: 466–73.
16.
JonesPJHSchoellerDA. Evidence for diurnal periodicity in human cholesterol synthesis. J Lipid Res1990; 31: 667–73.
17.
TerpstraJHesselLWSeepersJvan GentCM. The influence of meal frequency on diurnal lipid, glucose and cortisol levels in normal subjects. Eur J Clin Invest1978; 8: 61–6.
18.
RomonMNuttensM-CFievetCPotPBardJMFuronDIncreased triglyceride levels in shift workers. Am J Med1992; 93: 259–62.
19.
RippeyRM. Overview: Seasonal variations in cholesterol. Prev Med1981; 10: 655–9.
20.
RobinsonDBevanEAHinoharaSTakahashiT.Seasonal variation in serum cholesterol levels—evidence from the UK and Japan. Atherosclerosis1992; 95: 15–24.
21.
GordonDJTrostDCHydeJWhaleyFSHannanPJJacobsDRJrSeasonal cholesterol cycles: The Lipid Research Clinics Coronary Primary Prevention Trial placebo group. Circulation1987; 76: 1224–31.
22.
LockitchJRHalsteadACAlbersteinSMacCallumCQuigleyA.Age and sex specific paediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 analyser. Clin Chem1980; 34: 1622–5.
23.
ScottPHWhartonBA. Biochemical values in the newborn. In: RobertonN, ed. Textbook of Neonatology, 2nd edn.Edinburgh: Churchill Livingstone, 1992: 1213–29.
24.
ClaytonBEJenkinsPRoundJR. Paediatric Chemical Pathology: Clinical Tests and Reference Ranges. Oxford: Blackwell, 1980.
25.
Lipid Research Clinics Program Epidemiology Committee. Plasma lipid distributions in selected North American populations: The Lipid Research Clinics Program Prevalence Study. Circulation1979; 60: 427–39.
26.
TamirIHeissGGlueckCJChristensenBKwiterovichPRifkindBM. Lipid and lipoprotein distributions in white children ages 6–19 yr. The Lipid Research Clinics Program Prevalence Study. J Chronic Dis1981; 34: 27–39.
27.
HeissGTamirIDavisCETyrolerHARifkindBMSchonfeldGLipoprotein-cholesterol distributions in selected North American populations; the Lipid Research Clinics Program Prevalence Study. Circulation1980; 61: 302–15.
28.
Low-BeerTSWicksACBHeatonKWDurringtonPYeatesJ.Fluctuations of serum and bile lipid concentrations during the menstrual cycle. BMJ1977; 1: 1568–70.
29.
HemerHAde BourgesVVAyalaJJBritoGDíaz-SánchezVGarza-FloresJ.Variations in serum lipids and lipoproteins throughout the menstrual cycle. Fertil Steril1985; 44: 80–4.
30.
JonesDYJuddJTTaylorPRCampbellWSNairPP. Menstrual cycle effect on plasma lipids. Metabolism1988; 37: 1–2.
31.
Lussier-CacanSXhignesseMDesmaraisJ-LDavignonJKafrissenMEChapdelaineA.Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: Comparison with changes occurring during oral contraceptive therapy. Metabolism1991; 40: 849–54.
32.
LebechA-MKjaerALebechPE. Metabolic changes during the normal menstrual cycle: A longitudinal study. Am J Obstet Gynecol1990; 163: 414–6.
33.
WoodsMSchaeferEJMorrillAGoldinBRLongcopeCDwyerJDEffect of menstrual cycle phase on plasma lipids. J Clin Endocrinol Metab1987; 65: 321–3.
34.
ReineUAnsahBVoigtKD. Effect of the menstrual cycle on carbohydrate and lipid metabolism in normal females. Acta Endocrinol1972; 69: 762–8.
35.
LindT.Clinical chemistry of pregnancy. Adv Clin Chem1980; 1: 1–24.
36.
FåhraeusLLarsson-CohnUWallentinL.Plasma lipoproteins including high density lipoprotein subfractions during normal pregnancy. Obstet Gynecol1985; 66: 468–72.
37.
RifaiNMcMurrayRG. Serum lipid and apolipoprotein changes in normal pregnancy. Clin Chem1989; 35: 1066.
38.
HillmanLSchonfeldGMillerJPWulffG.Apolipoproteins in human pregnancy. Metabolism1975; 24: 943–52.
39.
RosingUSamsioeGÖlundAJohanssonBKallnerA.Serum levels of apolipoprotein A-I, A-II and HDL-cholesterol in second half of normal pregnancy and in pregnancy complicated by preeclampsia. Horm Metab Res1989; 21: 376–82.
40.
KnoppRHBergelinROWahlPWWaldenCE. Effects of pregnancy, postpartum lactation, and oral contraceptive use on the lipoprotein cholesterol/triglyceride ration. Metabolism1985; 34: 893–9.
41.
WarthMRArkyRAKnoppRH. Lipid metabolism in pregnancy. III. Altered lipid composition in intermediate, very low, low and high-density lipoprotein fractions. J Clin Endocrinol Metab1975; 41: 649–55.
42.
LaRosaJC. Lipids and cardiovascular disease: Do the findings and therapy apply equally to men and women?Womens Hlth Issues1992; 2: 102–11.
43.
McDonald-GibsonRGYoungMHyttenFE. Changes in plasma non-esterified fatty acids and serum glycerol in pregnancy. Br J Obstet Gynaecol1975; 82: 460–6.
44.
KnoppRHWaldenCEWahlPWBergelinRChapmanMIrvineSEffect of postpartum lactation on lipoprotein lipids and apoproteins. J Clin Endocrinol Metab1985; 60: 542–7.
45.
PanteghiniMPaginiF.Serum concentrations of lipoprotein (a) during normal pregnancy and postpartum. Clin Chem1991; 37: 2009–10.
46.
ZechnerRDesoyeGSchweditschMOPfeifferKPKostnerGM. Fluctuations of plasma lipoprotein-a concentrations during pregnancy and post partum. Metabolism1986; 35: 333–6.
47.
GrundySMDenkeMA. Dietary influences on serum lipids and lipoproteins. J Lipid Res1990; 31: 1149–72.
48.
SacksFMOrnishDRosnerBMcLanahanSCastelliWPKassEH. Plasma lipoprotein levels in vegetarians. J Am Med Assoc1985; 254: 1337–41.
49.
KeysAAndersonJTGrandeF.Serum cholesterol response to changes in the diet. IV. Particular saturated fatty acids in the diet. Metabolism1965; 14: 776–87.
50.
KeysAAndersonJTGrandeF.Serum cholesterol responses to changes in the diet. I. Iodine value of dietary fat versus 2S-P. Metabolism1965; 14: 747–58.
51.
HillJOPetersJCYangDSharpTKalerMAbumradNNThermogenesis in humans during overfeeding with medium-chain triglycerides. Metabolism1989; 38: 641–8.
52.
HarrisWSConnorWEIllingworthDRRothrockDWFosterDM. Effects of fish oil on VLDL triglyceride kinetics in humans. J Lipid Res1990; 31: 1549–58.
53.
EdelsteinSLBarrett-ConnorELWingardDLCohnBA. Increased meal frequency associated with decreased cholesterol concentrations; Rancho Bernardo, CA, 1984–1987. Am J Clin Nutr1992; 55: 664–9.
54.
SwainJFRouseILCurleyCBSacksFM. Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med1990; 322: 147–52.
55.
Le StunffCBougnèresPF. Glycerol production and utilisation during the early phase of human obesity. Diabetes1992; 41: 444–50.
56.
JanssonP-ALarssonASmithULönnrothP.Glycerol production in subcutaneous adipose tissue in lean and obese humans. J Clin Invest1992; 89: 1610–7.
57.
YaleJ-FLeiterLAMarlissEB. Metabolic responses to intense exercise in lean and obese subjects. J Clin Endocrinol Metab1989; 68: 662–5.
58.
De PergolaGGiorginoFCospiteMRGiogulliVACignarelliMFerriGRelation between sex hormones and serum lipoprotein (a) concentrations in premenopausal obese women. Arterioscler Thromb1993; 13: 675–9.
59.
DattiloAMKris-EthertonPM. Effects of weight reduction on blood lipids and lipoprotein: A meta-analysis. Am J Clin Nutr1992; 56: 320–8.
60.
WoodPDHaskellWL. The effect of exercise on plasma high density lipoproteins. Lipids1979; 14: 417–27.
61.
HardmanAEHudsonAJonesPNorganNG. Brisk walking and plasma high density lipoprotein cholesterol concentration in previously sedentary women. BMJ1989; 299: 1204–5.
62.
MartiBSuterERiesenWFTschoppAWannerH-UGutzwillerF.Effects of long-term, self-monitored exercise on the serum lipoprotein and apolipoprotein profile in middle-aged men. Atherosclerosis1990; 81: 19–31.
63.
LoboRANotelovitzMBernsteinLKhanFYRossRKPaulWL. Lp(a) lipoprotein: Relationship to cardiovascular disease risk factors, exercise, and estrogen. Am J Obstet Gynecol1992; 166: 1182–90.
64.
LampmanRMSantingaJTHodgeMF La ValleyBlockWDFloraJDBassettDR. Comparative effects of physical training and diet in normalising serum lipids in men with type IV hyperlipoproteinaemia. Circulation1977; 55: 652–9.
65.
WoodPDStefanickMLWilliamsPTHaskellWL. The effects of plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med1991; 325: 461–6.
66.
PayHEHardmanAEJonesGJHudsonA.The acute effects of low-intensity exercise on plasma lipids in endurance trained and untrained young adults. Eur J Appl Physiol1992; 64: 182–6.
67.
KrumHConwayELHowesLG. Acute effects of exercise on plasma lipids, noradrenaline levels and plasma volume. Clin Exp Pharmacol Physiol1991; 18: 697–701.
CraigWYPalomakiGEHaddowJE. Cigarette smoking and serum lipid and lipoprotein concentrations: An analysis of published data. BMJ1989; 298: 784–8.
70.
CraigWYPalomakiGEJohnsonAMHaddowJE. Cigarette smoking-associated changes in blood lipid and lipoprotein levels in the 8- to 19-year-old age group: A meta-analysis. Pediatrics1990; 85: 155–8.
71.
CadeJMargettsB.Cigarette smoking and serum lipid and lipoprotein concentrations. BMJ1989; 298: 1312.
72.
StamfordBAMatterSFellRDPapanekP.Effects of smoking cessation on weight gain, metabolic rate, caloric consumption, and blood lipids. Am J Clin Nutr198643: 486–94.
73.
MoffattRJ. Effects of cessation of smoking on serum lipids and high density lipoprotein-cholesterol. Atherosclerosis1988; 74: 85–9.
74.
MasareiJRLPuddeyIBVandongenRBeilinLJLynchWJ. Effect of smoking cessation on serum apolipoprotein A-I and A-II concentrations. Pathology1991; 23: 98–102.
75.
QuenselMSöderströmAAgardhCDNilsson-EhleP.High density lipoprotein concentrations after cessation of smoking: The importance of alterations in diet. Atherosclerosis1989; 75: 189–93.
76.
CastelliWPGordonTHjortlandMCKaganADoyleJTHamesCGAlcohol and blood lipids. Lancet1977; ii: 153–5.
SuperkoHR. Effects of acute and chronic alcohol consumption on postprandial lipemia in healthy normotriglyceridemic men. Am J Cardiol1992; 69: 701–4.
79.
VeenstraJOckhuizenTvan de PolHWedelMSchaafsmaG.Effects of a moderate dose of alcohol on blood lipids and lipoproteins postprandially and in the fasting state. Alcohol1990; 25: 371–7.
80.
GinsbergHOlefskyJFarquharJWReavenGM. Moderate ethanol ingestion and plasma triglyceride levels. A study in normal and hypertriglyceridemic persons. Ann Intern Med1974; 80: 143–9.
81.
SchneiderJLiesenfeldAMordasiniRSchabotzRZöfelPKubelFLipoprotein fractions, lipoprotein lipase and hepatic triglyceride lipase and hepatic triglyceride lipase during short-term and long-term uptake of ethanol in healthy subjects. Atherosclerosis1985; 57: 281–91.
82.
BoothSCliftonPMNestelPJ. Lack of effect of acute alcohol ingestion on plasma lipids. Clin Chem1991; 37: 1649.
83.
TaskinenM-RNikkiläEAVälimäkiMSaneTKuusiTKesäniemiYAAlcohol-induced changes in serum lipoproteins and their metabolism. Am Heart J1987; 113: 458–64.
84.
WolfeBMHavelRJMarlissEBEffects of a three-day fast and of ethanol on splanchnic metabolism of free fatty acids, amino acids and carbohydrates in healthy young men. J Clin Invest1976; 57: 329–40.
85.
HaskellWLCamargoCWilliamsPTVranizanKMKraussRMLindgrenFTThe effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. controlled study. N Engl J Med1984; 310: 805–10.
86.
MasareiJRLPuddeyIBLynchWJVandongenRBeilinLJ. Effects of alcohol consumption on serum lipoprotein-lipid and apolipoprotein concentrations. Results from an intervention study in healthy subjects. Atherosclerosis1986; 60: 79–87.
87.
LuomaPVSotaniemiEPelkonenROEhnholmC.High density lipoproteins and hepatic microsomal enzyme induction in alcohol consumers. Res Commun Chem Pathol Pharmacol1982; 37: 91–6.
88.
ThelleDSHeydenSFodorJG. Coffee and cholesterol in epidemiological and experimental studies. Atherosclerosis1987; 67: 97–103.
89.
van DusseldorpMKatanMBDemackerPNM. Effect of decaffeinated versus regular coffee on serum lipoproteins. A 12-week double-blind trial. Am J Epidemiol1990; 132: 33–40.
90.
SuperkoHRBortzWWilliamsPTAlbersJJWoodPD. Caffeinated and decaffeinated coffee effects on plasma lipoprotein cholesterol, apolipoproteins, and lipase activity: A controlled randomised trial. Am J Clin Nutr1991; 54: 599–605.
91.
BurrMLGallacherJEJButlandBKBoltonCHDownsLG. Coffee, blood pressure and plasma lipids: A randomised controlled trial. Eur J Clin Nutr1989; 43: 477–83.
92.
NaismithDJAkinanjuPASzantoSYudkinJ.The effect in volunteers of coffee and decaffeinated coffee on blood glucose, insulin, plasma lipids and some factors involved in blood clotting. Nutr Metab1970; 12: 144–51.
93.
BakAAAGrobbeeDE. Caffeine, blood pressure and serum lipids. Am J Clin Nutr1991; 53: 971–5.
94.
AroAKostiainenEHuttunenJKSeppäläEVapaataloH.Effects of coffee and tea on lipoproteins and prostanoids. Atherosclerosis1985; 57: 123–8.
95.
HillC.Coffee consumption and cholesterol concentrations. BMJ1985; 290: 1590.
96.
LindahlBJohanssonLHuhtasaariFHallmansGAsplundK.Coffee drinking and blood cholesterol—effects of brewing method, food intake and life style. J Intern Med1991; 230: 299–305.
97.
PietinenPAroATuomilehtoJUusitaloUKorhonenH.Consumption of boiled coffee is correlated with serum cholesterol in Finland. Int J Epidemiol1990; 19: 586–90.
98.
StensvoldLTverdalAFossOP. The effect of coffee on blood lipids and blood pressure. Results from a Norwegian cross-sectional study, men and women, 40–42 years. J Clin Epidemiol1989; 42: 877–84.
99.
AholaLJauhiainenMAroA.The hypercholesterolaemic factor in boiled coffee is retained by a paper filter. J Intern Med1991; 203: 293–7.
100.
van DusseldorpMKatanMBvan VlietTDemackeerPNMStalenhoefAFH. Cholesterol-raising factor from boiled coffee does not pass a paper filter. Arterioscler Thromb1991; 11: 586–93.
101.
AroATeiriläJGrefC-G.Dose-dependent effect on serum cholesterol and apoprotein B concentrations by consumption of boiled, non-filtered coffee. Atherosclerosis1990; 83: 257–61.
102.
ZockPLKatanMBMerkusMPvan DusseldorpMHarryvanJL. Effect of a lipid-rich fraction from boiled coffee on serum cholesterol. Lancet1990; 335: 1235–7.
103.
KroneWNägeleH.Effects of antihypertensives on plasma lipids and lipoprotein metabolism. Am Heart J1988; 116: 1729–34.
104.
BurkmanRT. Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy. Fertil Steril1988; 49 (suppl): 39S–50S.
105.
CrookDSeedM.Endocrine control of plasma lipoprotein metabolism: Effects of gonadal steroids. Clin Endocrinol Metab1990; 4: 851–75.
106.
UptonGV. Lipids, cardiovascular disease, and oral contraceptives: A practical perspective. Fertil Steril1990; 53: 1–12.
107.
SomaMROsnago-GaddaIPaolettiRFumagalliRMorrisettJDMeschiaMThe lowering of lipoprotein (a) induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch Int Med1993; 153: 1462–8.
108.
CrookDCustMPGangarKFWorthingtonMHillardJCStevensonJCComparison of transdermal and oral estrogen-progestin replacement therapy: Effects on serum lipids and lipoproteins. Am J Obstet Gynecol1992; 166: 950–5.
109.
MattsonLÅSamsioeGvon SchoultzBUverbrantMWilkundI.Transdermally administered oestradiol combined with oral medroxyprogesterone in postmenopausal women. Br J Obstet Gynaecol1993; 100: 450–3.
110.
HooperPLWooWViscontiLPathakDR. Terbutaline raises high-density-lipoprotein-cholesterol levels. N EnglJ Med1981; 305: 1455–7.
111.
MarsdenJR. Lipid metabolism and retinoid therapy. Pharmacol Ther1988; 40: 55–65.
112.
LakerMFGreenCBhuiyanAKMJShusterS.Isotretinoin and serum lipids: Studies on fatty acid, apolipoprotein and intermediary metabolism. Br J Dermatol1987; 117: 203–6.
113.
López-MirandaJPérez-JiménezFTorresAEspino-MontaroAGomezPHidalgo-RojasL.Effect of cyclosporin on plasma lipoproteins in bone marrow transplantation patients. Clin Biochem1992; 25: 379–86.
114.
NikkiläEAKasteMEhnholmCViikariJ.Increase of serum high-density lipoprotein in phenytoin users. BMJ1978; ii: 99.
115.
CalandreEPPortaBSde la CalzadaDG. The effect of chronic phenytoin treatment on serum lipid profile in adult epileptic patients. Epilepsia1992; 33: 154–7.
116.
LoumaPVMyllyläVVSotaniemiEALehtinenIAHokkanenEJ. Plasma high-density lipoprotein cholesterol in epileptics treated with various anticonvulsants. Eur Neurol1980; 19: 67–72.
117.
DurringtonPN. Effect of phenobarbitone on plasma apolipoprotein B and plasma high-density-lipoprotein cholesterol in normal subjects. Clin Sci1979; 56: 501–4.
118.
DurringtonPNRobertsCJCJacksonLBranchRAHartogM.Effect of phenobarbitone on plasma lipids in normal subjects. Clin Sci Mol Med1976; 50: 349–53.
119.
CalandreEPRodriguez-LopezCBlazquezACanoD.Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Acta Neurol Scand1991; 83: 250–3.
120.
IsojärviJITPakarinenAJMyllyläVV. Serum lipid levels during carbamazepine medication. A prospective study. Arch Neurol1993; 50: 590–3.
121.
PorteDBiermanEL. The effect of heparin infusion on plasma triglyceride in vivo and in vitro and with a method for calculating triglyceride turnover. J Lab Clin Med1969; 73: 631–48.
122.
HortinGLColeTGGibsonDWKesslerG.Decreased stability of triglycerides and increased free glycerol in serum from heparin-treated patients. Clin Chem1988; 34: 1847–9.
123.
OliverRM. Toxic effects of 2,3,7,8 tetrachlorodibenzo 1,4 dioxin in laboratory workers. Br J Ind Med1975; 32: 49–53.
124.
CarlsonLAKolmodin-HedmanB.Decrease in α-lipoprotein cholesterol in men after cessation of exposure to chlorinated hydrocarbon pesticides. Acta Med Scand1977; 201: 375–6.
125.
GoreJMGoldbergRJMatsumotoASCastelliWPMcNamaraPMDalenJE. Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am J Cardiol1984; 54: 722–5.
126.
AhnveSAngelinBEdhagOBerglundL.Early determination of serum lipids and apolipoproteins in acute myocardial infarction: Possibility for immediate intervention. J Intern Med1989; 226: 297–301.
127.
SewdarsenMVythilingumSJialalINadarR.Plasma lipids can be reliably assessed within 24 hours after acute myocardial infarction. Postgrad Med J1988; 64: 352–6.
128.
FyfeTCochranKMBaxterRHBoothEM. Plasma-lipid changes after myocardial infarction. Lancet1971; ii: 997–1001.
129.
RyderREJHayesTMMulliganIPKingswoodJCWilliamsSOwensDR. How soon after myocardial infarction should plasma lipid values be assessed?BMJ1984; 289: 1651–3.
130.
AvogaroPBonG BittoloCazzolatoGQuinciGBSansonASparlaMVariations in apolipoproteins B and A1 during the course of myocardial infarction. Eur J Clin Invest1978; 8: 121–9.
131.
Fahie-WilsonMMillsRWilsonK.HDL cholesterol and the acute phase reaction following myocardial infarction and acute pancreatitis. Clin Chim Acta1987; 167: 197–209.
132.
SammalkorpiKValtonenVKerttulaYNikkiläETaskinenM-R.Changes in serum lipoprotein pattern induced by acute infections. Metabolism1988; 37: 859–65.
PattonJSShepardHMWilkingHLewisGAggarwalBBEessaluTEInterferons and tumour necrosis factors have similar catabolic effects on 3T3 L1 cells. Proc Natl Acad Sci USA1986; 83: 8313–17.
136.
AlvarezCRamosA.Lipids, lipoproteins and apoproteins in serum during infection. Clin Chem1986; 32: 142–5.
137.
LindhALindholmMHolmquistLCarlsonLA. Time course for the changes of serum lipoproteins and apolipoprotein concentrations after major surgical trauma in man. J Parent Enteral Nutrition1986; 10: 265–73.
138.
CoombesEJShakespearePGBatstoneGF. Lipoprotein changes after burn injury in man. J Trauma1980; 20: 971–5.
139.
HarrisRLFrenkelRACottamGLBaxterCR. Lipid mobilisation and metabolism after thermal trauma. J Trauma1982; 22: 194–8.
140.
LawMRThompsonSG. Low serum cholesterol and the risk of cancer: An analysis of the published prospective studies. Cancer Causes Cont1991; 2: 253–61.
141.
KritchevskySBWilcoskyTCMorrisDLTruongKNTyrolerHA. Changes in plasma lipid and lipoprotein cholesterol and weight prior to the diagnosis of cancer. Cancer Res1991; 51: 3198–203.
142.
SherwinRWWentworthDNCutlerJAHulleySBKullerLHStamlerJ.Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. J Am Med Assoc1987; 257: 943–8.
143.
GerhardssonMRosenqvistUAhlbomACarlsonL.Serum cholesterol and cancer—a retrospective case-control study. Int J Epidemiol1986; 15: 155–9.
144.
VitolsSBjörkholmMGahrtonGPetersonC.Hypocholesterolaemia in malignancy due to elevated low-density-lipoprotein-receptor activity in tumour cells: Evidence from studies in patients with leukaemia. Lancet1985; ii: 1150–3.
145.
AxelopoulosCGBlatsiosBAvgerinosA.Serum lipids and lipoprotein disorders in cancer patients. Cancer1987; 60: 3065–70.
SeriesJJBiggartEMO'ReillyDSt JPackardCJShepherdJ.Thyroid dysfunction and hypercholesterolaemia in the general population of Glasgow, Scotland. Clin Chim Acta1988; 172: 217–22.
150.
MulsEBlatonVRosseneuMLesaffreELamberigtsGde MoorP.Serum lipids and apolipoproteins A-I, A-II, and B in hyperthyroidism before and after treatment. J Clin Endocrinol Metab1982; 55: 459–64.
151.
MillerJP. Dyslipoproteinaemia of liver disease. Clin Endocrinol Metab1990; 4: 807–32.
152.
BluestoneRLewisBMervartL.Hyperlipoproteinaemia in gout. Ann Rheum Dis1971; 30: 134–7.
153.
FernsGAALanhamJDieppePGaltonDJ. A DNA polymorphism of an apoprotein gene associates with the hypertriglyceridaemia of primary gout. Hum Genet1988; 78: 55–9.
154.
MacfarlaneDGMidwinterCADieppePABoltonCHHartogM.Demonstration of an abnormality of C apoprotein of very low density lipoprotein in patients with gout. Ann Rheum Dis1985; 44: 390–4.
155.
ShortCDDurringtonPN. Hyperlipidaemia and renal disease. Clin Endocrinol Metab1990; 4: 777–806.
156.
MordasiniRKloseGGretonH.Secondary type 11 hyperlipoproteinaemia in patients with anorexia nervosa. Metabolism1978; 27: 71–9.
157.
CohnJSMcNamaraJRCohnSDOrdovasJMSchaeferEJ. Postprandial plasma lipoprotein changes in huma subjects of different ages. J Lipid Res1988; 29: 469–79.
158.
MannJITruswellAS. Effect of controlled breakfast on serum cholesterol and triglycerides. Am J Clin Nutr1971; 24: 1300.
159.
RifaiNMerrillJRHollyRG. Postprandial effect of a high fat meal on plasma lipid, lipoprotein cholesterol and apolipoprotein measurements. Ann Clin Biochem1990; 27: 489–93.
160.
CohnJSLamCWKSullivanDRHensleyWJ. Plasma lipoprotein distribution of apolipoprotein(a) in the fed and fasted states. Atherosclerosis1991; 90: 59–66.
161.
MarkelABrookJGAviramM.Increased plasma triglycerides, cholesterol and apolipoprotein E during prolonged fasting in normal subjects. Postgrad Med J1985; 61: 395–400.
162.
WallentinLSköldstamL.Lipoproteins and cholesterol esterification rate in plasma during a 10-day modified fast in man. Am J Clin Nutr1980; 33: 1925–31.
163.
MillerMBachorikPSCloeyTA. Normal variation of plasma lipoprotein: Postural effects on plasma concentrations of lipids, lipoproteins, and apolipoprotein. Clin Chem1992; 38: 569–74.
164.
TanMHWilmshurstEGGleasonRESoeldnerJS. Effect of posture on serum lipids. N Engl J Med1973; 289: 416–9.
165.
KjeldsenSEEideILerenPFossOP. Effects of posture on serum cholesterol fractions, cholesterol ratio and triglycerides. Scand J Clin Lab Invest1983; 43: 119–21.
166.
HaganRDUptonSJAvakianEVGrundyS.Increases in serum lipid and lipoprotein levels with movement from the supine to standing position in adult men and women. Prev Med1986; 25: 18–27.
167.
StokerDJWynnV.Effects of posture on the plasma cholesterol level. BMJ1966; i: 336–8.
168.
HowesLGKrumHLouisWJ. Plasma cholesterol levels are dependent on sympathetic activity. J Hypertens1987; 5 (suppl 5): S361–3.
169.
DixonMPatersonCR. Posture and the composition of plasma. Clin Chem1978; 24: 824–6.
170.
StatlandBEWinkelP.Variations of cholesterol and total lipid concentrations in sera of healthy young men. Am J Clin Path1976; 66: 935–43.
171.
StatlandBEBokelundHWinkelP.Factors contributing to intra-individual variation of serum constituents: 4. Effects of posture and torniquet application on variation of serum constituents in healthy subjects. Clin Chem1974; 20: 1513–9.
172.
FeldingPTrydingNPetersenP HyltoftHorderM.Effects of posture on concentrations of blood constituents in healthy adults: Practical application of blood specimen collection procedures recommended by the Scandinavian Committee on Reference Values. Scand J Clin Lab Invest1980; 40: 615–21.
173.
EisenbergS.Postural changes in plasma volume in hypoalbuminemia. Arch Int Med1963; 112: 544–9.
174.
EisenbergSWolfPC. Plasma volume after posture change in hypertensive subjects. Arch Int Med1965; 115: 17–22.
175.
PageIHMoinuddinM.The effect of venous occlusion on serum cholesterol and total protein concentration—a warning. Circulation1962; 25: 651–2.
176.
KoerselmanHBLewisBPilkingtonTRE. The effect of venous occlusion on the level of serum cholesterol. J Atheroscler Res1961; 1: 85–8.
177.
GerbrandyJvan LeeuwenAMHellendoomHBAde VriesLA. The binding between electrolytes and serum proteins calculated from an in vivo filtration method. Clin Sci1960; 19: 181–93.
178.
EvansKMitchesonJBuhagiarGCLakerMF. Effects of venous occlusion on lipid, lipoprotein and apolipoprotein concentrations. Clin Sci1993; 85 (suppl 29): 17P.
179.
SperryWMSchoenheimerR.A comparison of serum, heparinised plasma, and oxalated plasma in regard to cholesterol content. J Biol Chem1935; 110: 655–8.
180.
GrandeFAmatuzioDSWadaS.Cholesterol measurement in serum and in plasma. Clin Chem1964; 10: 619–26.
181.
AlperC.Specimen collection and preservation. In: HenryRJCannonDCWinkelmanJW, eds. Clinical Chemistry: Principles and Technics. New York: Harper and Row, 1974: 373–88.
182.
CloeyTBachorikPSBeckerDFinneyCLowryDSigmundW.Reevaluation of serum-plasma differences in total individual concentration. J Am Med Assoc1990; 263: 2788–9.
183.
LumGGambinoSR. A comparison of serum versus heparinized plasma for routine chemistry tests. Am J Clin Path1974; 61: 108–13.
184.
LadensonJHTsaiL-MBMichaelJMKesslerGJoistJH. Serum versus heparinised plasma for eighteen common chemistry tests. Is serum the appropriate specimen?Am J Clin Path1974; 62: 545–52.
185.
Laboratory Methods Committee. Cholesterol and triglyceride concentrations in serum/plasma pairs. Clin Chem1977; 23: 60–3.
186.
National Cholesterol Education Program Expert Panel. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Int Med1988; 148: 36–69.
187.
WickusGGDukerscheinRO. Serum-plasma differences in total cholesterol: What correction factor should be used?J Am Med Assoc1992; 267: 234–5.
188.
AlzofonJTiltonKAHaleyNJ. Enzymic determination of cholesterol in plasma obtained by fingerstick. Clin Chem1985; 31: 168.
189.
DörnerKDorn-ZachertzD.Cholesterol determinations from skin puncture and venous blood have similar imprecisions. J Clin Chem Clin Biochem1991; 29: 411–3.
190.
BoermaGJMLiemTLHaasJAL Jacobs-Dede Jong-Van StaverenFACVerbreeWEmanI.The reflotron total cholesterol assay in heparinised venous and capillary blood. J Clin Chem Clin Biochem1990; 28: 255–8.
191.
KupkeIRZeugnerSGottschalkAKatherB.Differences in lipid and lipoprotein concentrations of capillary and venous samples. Clin Chim Acta1979; 97: 279–83.
BachorikPSCloeyTAFinneyCALowryDRBeckerDM. Lipoprotein-cholesterol analysis during screening: Accuracy and reliability. Ann Intern Med1991; 114: 741–7.
194.
BoermaGJMGelderlandJvan GorpILeijnseB.Use of the reflotron system for cholesterol assay in capillary blood, venous blood, and serum-evaluation of accuracy and lot-to-lot reagent comparability. Clin Chem1988; 34: 2117–9.
195.
BachorikPSRockRCloeyTTreciakEBeckerDSigmundW.Cholesterol screening: Comparative evaluation of on-site and laboratory-based measurements. Clin Chem1990; 255–60.
196.
MeloyNSteinE.Comparison of fingerstick whole blood and venous plasma HDL-cholesterols. Clin Chem1990; 36: 964.
197.
LippiUGrazianiMSSchinellaMManzatoFBazzaniR.Determination of high density lipoprotein cholesterol in venous and capillary whole blood. J Lipid Res1988; 29: 112–5.
198.
WarnickGRBoermaGJMAssmannGEndlerATGeriqueGGottoAMMulticenter evaluation of reflotron direct dry-chemistry assay of high-density lipoprotein cholesterol in venous and fingerstick specimens. Clin Chem1993; 39: 271–7.
199.
NishidaTKummerowFA. Interaction of serum lipoproteins with the hydroperoxide of methyl linoleate. J Lipid Res1960; 1: 450–8.
200.
SchwertnerHAFriedmanHS. Changes in lipid values and lipoprotein patterns of serum samples contaminated with bacteria. Am J Clin Path1973; 59: 829–35.
201.
EdelsteinCGordonJIToscasKSimsHFStraussAWScanuAM. In vitro conversion of proapoprotein A-1 to apoprotein A-1. J Biol Chem1983; 258: 11430–3.
202.
EdelsteinCScanuAM. Precautionary measures for collecting blood destined for lipoprotein isolation. Methds Enzymol1986; 128: 151–5.
203.
KuchmakMTaylorLOlanskyAS. Suitability of frozen and lyophilised reference sera for cholesterol and triglyceride determinations. Clin Chim Acta1982; 120: 261–71.
204.
HankinsonSELondonSJChuteCGBarbieriRLJonesLKaplanLAEffect of transport conditions on the stability of biochemical markers in blood. Clin Chem1989; 35: 2313–6.
205.
VirdiNKWorthingtonDJ. Cholesterol and triglyceride stability in whole blood. Ann Clin Biochem1989; 26: 197–8.
206.
BrownSAEppsDFDunnJKSharrettARPatschJRGottoAMJrEffect of blood collection and processing on radioimmunoassay results for apolipoprotein B in plasma. Clin Chem1990; 36: 1662–6.
207.
KafonekSBachorikPSKwiterovichPO. Measurement of apolipoprotein B in plasma from hyperlipidemic subjects treated with cholestyramine or placebo: Differential effects of storage at −70°C. Clin Chem1989; 35: 380–3.
208.
BrownSARhodesCEDunnKGottoAMJrPatschW.Effect of blood collection and processing on radioimmunoassay results for apolipoprotein A-1 in plasma. Clin Chem1988; 34: 920–4.
209.
WangXLDudmanNPBBladesBLWilckenDEL. Changes in the immunoreactivity of apo A-1 during storage. Clin Chim Acta1989; 179: 285–94.
210.
SgoutasDSTutenT.Effect of freezing and thawing of serum on the immunoassay of lipoprotein(a). Clin Chem1992; 38: 1873–7.
211.
CraigWYPoulinSEForsterNRNeveuxLMWaldNJLedueTB. Effect of sample storage on the assay of lipoprotein(a) by commercially available radial immunodiffusion and enzyme-linked immunosorbent assay kits. Clin Chem1992; 38: 550–3.
212.
RecklessJPDBetteridgeDJWuPPayneBGaltonDJ. Effect of storage on plasma-lipoproteins. Lancet1977; ii: 350.
213.
StokesYMSalmondCECarpenterLMWelbyTJ. Stability of total cholesterol, high-density-lipoprotein cholesterol, and triglycerides in frozen sera. Clin Chem1986; 32: 995–9.
214.
WarnickGRAlbersJJ. High-density-lipoprotein cholesterol quantitation: Effect of plasma storage on heparin-Min2 + supernatant cholesterol concentration. Clin Chem1979. 25: 1098–9.
215.
BachorikPSWalkerRBrownellKDStunkardAJKwiterovichPO. Determination of high density lipoprotein-cholesterol in stored human plasma. J Lipid Res1980; 21: 608–16.
216.
BachorikPSWalkerREKwiterovichPOJrDetermination of high density lipoprotein-cholesterol in human plasma stored at −70°C. J Lipid Res1982; 23: 1236–42.
217.
del GattoLNicholsAVLindgrenFT. Effects of freeze-thawing and storage on ultracentrifugal properties of human serum lipoproteins. Proc Soc Exp Biol Med1959; 101: 59–61.
218.
TiedinkHGMKatanMB. Variability in lipoprotein concentrations in serum after prolonged storage at −20°C. Clin Chim Acta1989; 180: 147–56.
219.
WinkelmanJWybengaDRIbbottFA. Phenotyping of hyperlipoproteinaemias. Clin Chem1970; 16: 507–11.